Bell & Brown Wealth Advisors, LLC Pfizer Inc Transaction History

Bell & Brown Wealth Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $1.3 Million - $1.86 Million	-48,092 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$32.92 - $37.36 $29,397 - $33,362	893 Added 1.89%	48,092 $1.95 Million
Q3 2019 Oct 09, 2019	BUY	$32.49 - $42.13 $54,713 - $70,946	1,684 Added 3.7%	47,199 $1.68 Million
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $77,325 - $86,818	2,091 Added 4.82%	45,515 $1.97 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $15,675 - $17,221	418 Added 0.97%	43,424 $1.84 Million
Q4 2018 Feb 22, 2019	SELL	$38.47 - $43.86 $2.61 Million - $2.97 Million	-67,772 Reduced 61.18%	43,006 $1.88 Million
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $2.62 Million - $2.99 Million	68,126 Added 159.73%	110,778 $4.84 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $14,649 - $17,769	425 Added 1.01%	42,652 $1.84 Million
Q2 2018 Jul 31, 2018	BUY	$32.98 - $35.16 $31,100 - $33,155	943 Added 2.28%	42,227 $1.53 Million
Q1 2018 May 02, 2018	BUY	$31.91 - $37.02 $65,096 - $75,520	2,040 Added 5.2%	41,284 $1.48 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $1.31 Million - $1.38 Million	39,244	39,244 $1.42 Million

3,256

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Bell & Brown Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bell & Brown Wealth Advisors, LLC with notifications on news.